Histone methyltransferase Setd8 represses Gata2 expression and regulates erythroid maturation

Molecular and Cellular Biology

Volumn 35, Issue 12, 2015, Pages 2059-2072

  Malik, Jeffrey ^a   Getman, Michael ^a   Steiner, Laurie A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HISTONE H4; HISTONE METHYLTRANSFERASE; PROTEIN SETD8; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; SETD8 PROTEIN, MOUSE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL NUCLEUS; CELL RENEWAL; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; ERYTHROBLAST; ERYTHROID CELL; FETUS; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; HISTONE ACETYLATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; ACETYLATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROMOTER REGION; RNA INTERFERENCE;

MAMMALIA;

ACETYLATION; ANIMALS; CELLS, CULTURED; ERYTHROBLASTS; ERYTHROID CELLS; ERYTHROPOIESIS; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84929395538     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01413-14     Document Type: Article

References (82)

1. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705. http://dx.doi.org/10.1016/j.cell.2007.02.005.
2. Woodcock CL, Ghosh RP. 2010. Chromatin higher-order structure and dynamics. Cold Spring Harb Perspect Biol 2:a000596. http://dx.doi.org/10.1101/cshperspect.a000596.
3. Bannister AJ, Kouzarides T. 2011. Regulation of chromatin by histone modifications. Cell Res 21:381-395. http://dx.doi.org/10.1038/cr.2011.22.
4. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, Ching KA, Antosiewicz-Bourget JE, Liu H, Zhang X, Green RD, Lobanenkov VV, Stewart R, Thomson JA, Crawford GE, Kellis M, Ren B. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459:108-112. http://dx.doi.org/10.1038/nature07829.
5. Zhang Z, Zhang MQ. 2011. Histone modification profiles are predictive for tissue/cell-type specific expression of both protein-coding and microRNA genes. BMC Bioinformatics 12:155. http://dx.doi.org/10.1186/1471-2105-12-155.
6. Steiner LA, Maksimova Y, Schulz V, Wong C, Raha D, Mahajan MC, Weissman SM, Gallagher PG. 2009. Chromatin architecture and transcription factor binding regulate expression of erythrocyte membrane protein genes. Mol Cell Biol 29:5399-5412. http://dx.doi.org/10.1128/MCB.00777-09.
7. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129:823-837. http://dx.doi.org/10.1016/j.cell.2007.05.009.
8. Stopka T, Amanatullah DF, Papetti M, Skoultchi AI. 2005. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. EMBO J 24:3712-3723. http://dx.doi.org/10.1038/sj.emboj.7600834.
9. Ross J, Mavoungou L, Bresnick EH, Milot E. 2012. GATA-1 utilizes Ikaros and polycomb repressive complex 2 to suppress Hes1 and to promote erythropoiesis. Mol Cell Biol 32:3624-3638. http://dx.doi.org/10.1128/MCB.00163-12.
10. Fujiwara T, Lee HY, Sanalkumar R, Bresnick EH. 2010. Building multifunctionality into a complex containing master regulators of hematopoiesis. Proc Natl Acad Sci U S A 107:20429-20434. http://dx.doi.org/10.1073/pnas.1007804107.
11. Yu M, Riva L, Xie H, Schindler Y, Moran TB, Cheng Y, Yu D, Hardison R, Weiss MJ, Orkin SH, Bernstein BE, Fraenkel E, Cantor AB. 2009. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell 36:682-695. http://dx.doi.org/10.1016/j.molcel.2009.11.002.
12. Oda H, Okamoto I, Murphy N, Chu J, Price SM, Shen MM, Torres-Padilla ME, Heard E, Reinberg D. 2009. Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development. Mol Cell Biol 29:2278-2295. http://dx.doi.org/10.1128/MCB.01768-08.
13. Takawa M, Cho HS, Hayami S, Toyokawa G, Kogure M, Yamane Y, Iwai Y, Maejima K, Ueda K, Masuda A, Dohmae N, Field HI, Tsunoda T, Kobayashi T, Akasu T, Sugiyama M, Ohnuma S, Atomi Y, Ponder BA, Nakamura Y, Hamamoto R. 2012. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. Cancer Res 72:3217-3227. http://dx.doi.org/10.1158/0008-5472.CAN-11-3701.
14. Yin Y, Yu VC, Zhu G, Chang DC. 2008. SET8 plays a role in controlling G1/S transition by blocking lysine acetylation in histone through binding to H4 N-terminal tail. Cell Cycle 7:1423-1432. http://dx.doi.org/10.4161/cc.7.10.5867.
15. Beck DB, Oda H, Shen SS, Reinberg D. 2012. PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription. Genes Dev 26:325-337. http://dx.doi.org/10.1101/gad.177444.111.
16. Oda H, Hubner MR, Beck DB, Vermeulen M, Hurwitz J, Spector DL, Reinberg D. 2010. Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage. Mol Cell 40:364-376. http://dx.doi.org/10.1016/j.molcel.2010.10.011.
17. Karachentsev D, Sarma K, Reinberg D, Steward R. 2005. PR-Set7-dependent methylation of histone H4 Lys 20 functions in repression of gene expression and is essential for mitosis. Genes Dev 19:431-435. http://dx.doi.org/10.1101/gad.1263005.
18. Congdon LM, Houston SI, Veerappan CS, Spektor TM, Rice JC. 2010. PR-Set7-mediated monomethylation of histone H4 lysine 20 at specific genomic regions induces transcriptional repression. J Cell Biochem 110: 609-619. http://dx.doi.org/10.1002/jcb.22570.
19. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K. 2009. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4:80-93. http://dx.doi.org/10.1016/j.stem.2008.11.011.
20. DeVilbiss AW, Boyer ME, Bresnick EH. 2013. Establishing a hematopoietic genetic network through locus-specific integration of chromatin regulators. Proc Natl Acad Sci U S A 110:E3398-E3407. http://dx.doi.org/10.1073/pnas.1302771110.
21. Li Y, Sun L, Zhang Y, Wang D, Wang F, Liang J, Gui B, Shang Y. 2011. The histone modifications governing TFF1 transcription mediated by estrogen receptor. J Biol Chem 286:13925-13936. http://dx.doi.org/10.1074/jbc.M111.223198.
22. Wakabayashi K, Okamura M, Tsutsumi S, Nishikawa NS, Tanaka T, Sakakibara I, Kitakami J, Ihara S, Hashimoto Y, Hamakubo T, Kodama T, Aburatani H, Sakai J. 2009. The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol 29:3544-3555. http://dx.doi.org/10.1128/MCB.01856-08.
23. Talasz H, Lindner HH, Sarg B, Helliger W. 2005. Histone H4-lysine 20 monomethylation is increased in promoter and coding regions of active genes and correlates with hyperacetylation. J Biol Chem 280:38814-38822. http://dx.doi.org/10.1074/jbc.M505563200.
24. Liu W, Tanasa B, Tyurina OV, Zhou TY, Gassmann R, Liu WT, Ohgi KA, Benner C, Garcia-Bassets I, Aggarwal AK, Desai A, Dorrestein PC, Glass CK, Rosenfeld MG. 2010. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 466:508-512. http://dx.doi.org/10.1038/nature09272.
25. Abbas T, Shibata E, Park J, Jha S, Karnani N, Dutta A. 2010. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol Cell 40:9-21. http://dx.doi.org/10.1016/j.molcel.2010.09.014.
26. Yu N, Huangyang P, Yang X, Han X, Yan R, Jia H, Shang Y, Sun L. 2013. microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8. J Biol Chem 288:19633-19642. http://dx.doi.org/10.1074/jbc.M113.475657.
27. Zhang BL, Song FJ, Zheng H, Zhang LN, Zhao YR, Chen KX. 2012. SNP rs16917496 within SET8 3'UTRis associated with the age of onset of breast cancer. Zhonghua Zhong Liu Za Zhi 34:835-837. (In Chinese.) http://dx.doi.org/10.3760/cma.j.issn.0253-3766.2012.11.008.
28. Guo Z, Wu C, Wang X, Wang C, Zhang R, Shan B. 2012. A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome. Int J Cancer 131:1318-1322. http://dx.doi.org/10.1002/ijc.27352.
29. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M. 2005. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37:391-400. http://dx.doi.org/10.1038/ng1531.
30. Valente S, Lepore I, Dell'Aversana C, Tardugno M, Castellano S, Sbardella G, Tomassi S, Di Maro S, Novellino E, Di Santo R, Costi R, Altucci L, Mai A. 2012. Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells. Biochimie 94:2308-2313. http://dx.doi.org/10.1016/j.biochi.2012.06.003.
31. Li Z, Nie F, Wang S, Li L. 2011. Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. Proc Natl Acad Sci U S A 108:3116-3123. http://dx.doi.org/10.1073/pnas.1009353108.
32. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW, III, Su AI. 2009. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10:R130. http://dx.doi.org/10.1186/gb-2009-10-11-r130.
33. Kingsley PD, Greenfest-Allen E, Frame JM, Bushnell TP, Malik J, McGrath KE, Stoeckert CJ, Palis J. 2013. Ontogeny of erythroid gene expression. Blood 121:e5-e13. http://dx.doi.org/10.1182/blood-2012-04-422394.
34. An X, Schulz VP, Li J, Wu K, Liu J, Xue F, Hu J, Mohandas N, Gallagher PG. 2014. Global transcriptome analyses of human and murine terminal erythroid differentiation. Blood 123:3466-3477. http://dx.doi.org/10.1182/blood-2014-01-548305.
35. England SJ, McGrath KE, Frame JM, Palis J. 2011. Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 117:2708-2717. http://dx.doi.org/10.1182/blood-2010-07-299743.
36. Getman M, England SJ, Malik J, Peterson K, Palis J, Steiner LA. 2014. Extensively self-renewing erythroblasts derived from transgenic beta-Yac mice are a novel model system for studying globin switching and erythroid maturation. Exp Hematol 42:536-46.e8. http://dx.doi.org/10.1016/j.exphem.2014.03.006.
37. Ikonomi P, Rivera CE, Riordan M, Washington G, Schechter AN, Noguchi CT. 2000. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. Exp Hematol 28:1423-1431. http://dx.doi.org/10.1016/S0301-472X(00)00553-1.
38. Persons DA, Allay JA, Allay ER, Ashmun RA, Orlic D, Jane SM, Cunningham JM, Nienhuis AW. 1999. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood 93: 488-499.
39. Briegel K, Lim KC, Plank C, Beug H, Engel JD, Zenke M. 1993. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev 7:1097-1109. http://dx.doi.org/10.1101/gad.7.6.1097.
40. Heyworth C, Gale K, Dexter M, May G, Enver T. 1999. A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal. Genes Dev 13:1847-1860. http://dx.doi.org/10.1101/gad.13.14.1847.
41. McGrath KE, Bushnell TP, Palis J. 2008. Multispectral imaging of hematopoietic cells: where flow meets morphology. J Immunol Methods 336:91-97. http://dx.doi.org/10.1016/j.jim.2008.04.012.
42. David M, Dzamba M, Lister D, Ilie L, Brudno M. 2011. SHRiMP2: sensitive yet practical SHort Read Mapping. Bioinformatics 27:1011-1012. http://dx.doi.org/10.1093/bioinformatics/btr046.
43. Roberts A, Pimentel H, Trapnell C, Pachter L. 2011. Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics 27:2325-2329. http://dx.doi.org/10.1093/bioinformatics/btr355.
44. Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210. http://dx.doi.org/10.1093/nar/30.1.207.
45. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N. 2009. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A 106:17413-17418. http://dx.doi.org/10.1073/pnas.0909296106.
46. Driskell I, Oda H, Blanco S, Nascimento E, Humphreys P, Frye M. 2012. The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin. EMBO J 31:616-629. http://dx.doi.org/10.1038/emboj.2011.421.
47. Sharma A, Singh K, Almasan A. 2012. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol 920:613-626. http://dx.doi.org/10.1007/978-1-61779-998-3_40.
48. Kramer A, Green J, Pollard J, Jr, Tugendreich S. 2014. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30:523-530. http://dx.doi.org/10.1093/bioinformatics/btt703.
49. Vicente C, Conchillo A, Garcia-Sanchez MA, Odero MD. 2012. The role of theGATA2transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol 82:1-17. http://dx.doi.org/10.1016/j.critrevonc.2011.04.007.
50. Dore LC, Chlon TM, Brown CD, White KP, Crispino JD. 2012. Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis. Blood 119:3724-3733. http://dx.doi.org/10.1182/blood-2011-09-380634.
51. Cheng Y, Wu W, Kumar SA, Yu D, Deng W, Tripic T, King DC, Chen KB, Zhang Y, Drautz D, Giardine B, Schuster SC, Miller W, Chiaromonte F, Zhang Y, Blobel GA, Weiss MJ, Hardison RC. 2009. Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res 19:2172-2184. http://dx.doi.org/10.1101/gr.098921.109.
52. Weiss MJ, Yu C, Orkin SH. 1997. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a genetargeted cell line. Mol Cell Biol 17:1642-1651.
53. Martowicz ML, Grass JA, Boyer ME, Guend H, Bresnick EH. 2005. DynamicGATAfactor interplay at a multicomponent regulatory region of the GATA-2 locus. J Biol Chem 280:1724-1732. http://dx.doi.org/10.1074/jbc.M406038200.
54. Grass JA, Jing H, Kim SI, Martowicz ML, Pal S, Blobel GA, Bresnick EH. 2006. Distinct functions of dispersed GATA factor complexes at an endogenous gene locus. Mol Cell Biol 26:7056-7067. http://dx.doi.org/10.1128/MCB.01033-06.
55. Kadauke S, Udugama MI, Pawlicki JM, Achtman JC, Jain DP, Cheng Y, Hardison RC, Blobel GA. 2012. Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1. Cell 150:725-737. http://dx.doi.org/10.1016/j.cell.2012.06.038.
56. Goecks J, Nekrutenko A, Taylor J. 2010. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 11:R86. http://dx.doi.org/10.1186/gb-2010-11-8-r86.
57. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineagedetermining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576-589. http://dx.doi.org/10.1016/j.molcel.2010.05.004.
58. Minegishi N, Ohta J, Suwabe N, Nakauchi H, Ishihara H, Hayashi N, Yamamoto M. 1998. Alternative promoters regulate transcription of the mouse GATA-2 gene. J Biol Chem 273:3625-3634. http://dx.doi.org/10.1074/jbc.273.6.3625.
59. Pan X, Minegishi N, Harigae H, Yamagiwa H, Minegishi M, Akine Y, Yamamoto M. 2000. Identification of human GATA-2 gene distal IS exon and its expression in hematopoietic stem cell fractions. J Biochem 127: 105-112. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022570.
60. Snow JW, Trowbridge JJ, Johnson KD, Fujiwara T, Emambokus NE, Grass JA, Orkin SH, Bresnick EH. 2011. Context-dependent function of "GATA switch" sites in vivo. Blood 117:4769-4772. http://dx.doi.org/10.1182/blood-2010-10-313031.
61. Snow JW, Trowbridge JJ, Fujiwara T, Emambokus NE, Grass JA, Orkin SH, Bresnick EH. 2010. A single cis element maintains repression of the key developmental regulator Gata2. PLoS Genet 6:e1001103. http://dx.doi.org/10.1371/journal.pgen.1001103.
62. Bresnick EH, Lee HY, Fujiwara T, Johnson KD, Keles S. 2010. GATA switches as developmental drivers. J Biol Chem 285:31087-31093. http://dx.doi.org/10.1074/jbc.R110.159079.
63. Johnson KD, Hsu AP, Ryu MJ, Wang J, Gao X, Boyer ME, Liu Y, Lee Y, Calvo KR, Keles S, Zhang J, Holland SM, Bresnick EH. 2012. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest 122:3692-3704. http://dx.doi.org/10.1172/JCI61623.
64. Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH. 2003. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A 100:8811-8816. http://dx.doi.org/10.1073/pnas.1432147100.
65. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH. 1994. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371:221-226. http://dx.doi.org/10.1038/371221a0.
66. Rodriguez P, Bonte E, Krijgsveld J, Kolodziej KE, Guyot B, Heck AJ, Vyas P, de Boer E, Grosveld F, Strouboulis J. 2005. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J 24:2354-2366. http://dx.doi.org/10.1038/sj.emboj.7600702.
67. Kalakonda N, Fischle W, Boccuni P, Gurvich N, Hoya-Arias R, Zhao X, Miyata Y, Macgrogan D, Zhang J, Sims JK, Rice JC, Nimer SD. 2008. Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene 27:4293-4304. http://dx.doi.org/10.1038/onc.2008.67.
68. Trojer P, Li G, Sims RJ, III, Vaquero A, Kalakonda N, Boccuni P, Lee D, Erdjument-Bromage H, Tempst P, Nimer SD, Wang YH, Reinberg D. 2007. L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 129:915-928. http://dx.doi.org/10.1016/j.cell.2007.03.048.
69. Nishioka K, Rice JC, Sarma K, Erdjument-Bromage H, Werner J, Wang Y, Chuikov S, Valenzuela P, Tempst P, Steward R, Lis JT, Allis CD, Reinberg D. 2002. PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol Cell 9:1201-1213. http://dx.doi.org/10.1016/S1097-2765(02)00548-8.
70. Miotto B, Struhl K. 2010. HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by Geminin. Mol Cell 37:57-66. http://dx.doi.org/10.1016/j.molcel.2009.12.012.
71. Pesavento JJ, Yang H, Kelleher NL, Mizzen CA. 2008. Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle. Mol Cell Biol 28:468-486. http://dx.doi.org/10.1128/MCB.01517-07.
72. Lu X, Simon MD, Chodaparambil JV, Hansen JC, Shokat KM, Luger K. 2008. The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure. Nat Struct Mol Biol 15:1122-1124. http://dx.doi.org/10.1038/nsmb.1489.
73. Sproul D, Gilbert N, Bickmore WA. 2005. The role of chromatin structure in regulating the expression of clustered genes. Nat Rev Genet 6:775-781. http://dx.doi.org/10.1038/nrg1688.
74. Johnson KD, Boyer ME, Kang JA, Wickrema A, Cantor AB, Bresnick EH. 2007. Friend of GATA-1-independent transcriptional repression: a novel mode of GATA-1 function. Blood 109:5230-5233. http://dx.doi.org/10.1182/blood-2007-02-072983.
75. Shimamoto T, Ohyashiki K, Ohyashiki JH, Kawakubo K, Fujimura T, Iwama H, Nakazawa S, Toyama K. 1995. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 86:3173-3180.
76. Ayala RM, Martinez-Lopez J, Albizua E, Diez A, Gilsanz F. 2009. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol 84:79-86. http://dx.doi.org/10.1002/ajh.21332.
77. Vicente C, Vazquez I, Conchillo A, Garcia-Sanchez MA, Marcotegui N, Fuster O, Gonzalez M, Calasanz MJ, Lahortiga I, Odero MD. 2012. Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities. Leukemia 26:550-554. http://dx.doi.org/10.1038/leu.2011.235.
78. Hoene V, Fischer M, Ivanova A, Wallach T, Berthold F, Dame C. 2009. GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes. Br J Cancer 101:1481-1489. http://dx.doi.org/10.1038/sj.bjc.6605276.
79. Bohm M, Locke WJ, Sutherland RL, Kench JG, Henshall SM. 2009. A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene 28: 3847-3856. http://dx.doi.org/10.1038/onc.2009.243.
80. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, Murday VA, Hodgson S, Keenan R, Pilz DT, Martinez-Corral I, Makinen T, Mortimer PS, Jeffery S, Trembath RC, Mansour S. 2011. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 43:929-931. http://dx.doi.org/10.1038/ng.923.
81. Ishiko E, Matsumura I, Ezoe S, Gale K, Ishiko J, Satoh Y, Tanaka H, Shibayama H, Mizuki M, Era T, Enver T, Kanakura Y. 2005. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J Biol Chem 280:4929-4939. http://dx.doi.org/10.1074/jbc.M406788200.
82. DeVilbiss AW, Sanalkumar R, Hall BDR, Katsumura KR, de Andrade IF, Bresnick EH. 2015. Epigenetic determinants of erythropoiesis: role of the histone methyltransferase SetD8 in promoting erythroid cell maturation and survival. Mol Cell Biol 35:2073-2087. http://dx.doi.org/10.1128/MCB.01422-14.